Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::CHANGE OF DIRECTOR'S INTEREST - MR LIM SEE WAH

Issuer & Securities

Issuer/ Manager
HYPHENS PHARMA INTERNATIONAL LIMITED
Securities
HYPHENS PHARMA INTL LIMITED - SG1EE4000006 - 1J5
Stapled Security
No

Announcement Details

Announcement Title
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast
19-Jul-2023 19:21:35
Status
New
Announcement Sub Title
CHANGE OF DIRECTOR'S INTEREST - MR LIM SEE WAH
Announcement Reference
SG230719OTHRI3GE
Submitted By (Co./ Ind. Name)
Lim See Wah
Designation
Executive Chairman and CEO
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Please refer to the attached Form 1.

This announcement has been reviewed by the Company's Sponsor, SAC Capital Private Limited (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited ( the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement including the correctness of any statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Lee Khai Yinn (Tel: +65 6232 3210) at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542.

Additional Details

Person(s) giving notice
Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer
19/07/2023

Attachments

2A. eFORM1V2_LSW_190723_final.pdf
if you are unable to view the above file, please click the link below.
_2A. eFORM1V2_LSW_190723_final.pdf
Total size =150K